PAREXEL International
Two PAREXEL Executives Named to 2017 PharmaVOICE 100
08.01.17
BOSTON, August 1, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Sy Pretorius, M.D., Senior Vice President and Chief Scientific Officer, and Evan Demestihas, M.D., RPh, Vice President, Worldwide Head of The Medical Affairs Company (TMAC), have been named to PharmaVOICE magazine’s list of the 100 most inspiring people in the life sciences industry. The honor, published in the July/August 2017 issue of PharmaVOICE, recognizes both leaders for their valuable contributions to the industry and dedication to improving patients’ lives, while also mentoring the next generation of industry leaders. Read Full Release
COTA
NJ Health System Pilots IBM Watson for Oncology Decision Support
07.10.17
IBM Watson for Oncology is getting a trial run at Hackensack Meridian Health, which is supplementing the cognitive computing tool with additional clinical decision support software. Read Full Release
COTA
Pharma turns to big data to gauge care and pricing
07.11.17
After many years building successful technology businesses, Jeremy Sohn never imagined that at 43 he would find himself on the payroll of a big pharmaceutical company. But 18 months ago he was appointed global head of digital business development and licensing at Swiss drugmaker Novartis. His appointment is evidence of how an industry, slow to respond to the disruption of digitisation, is grasping its importance as it confronts pricing pressures, ever-vaster quantities of patient data and more empowered consumers. Read Full Release
COTA
COTA’s Pecora named Executive of the Year at NJBIZ Healthcare Heroes
06.21.17
Dr. Andrew Pecora said he was honored and humbled when he received the Health Care Executive of the Year award at the NJBIZ Healthcare Heroes awards event Tuesday. Pecora, the president of physician services and chief innovation officer at Hackensack Meridian Health, was quick to recognize his colleagues in the crowd as well as the other honorees at the event. Read Full Release
PAREXEL International
PAREXEL International Enters Definitive Agreement to be Acquired by Pamplona Capital Management for $88.10 Per Share in Cash
06.20.17
BOSTON and NEW YORK, June 20, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, and Pamplona Capital Management, LLP (Pamplona) today announced that they have entered into a definitive agreement under which Pamplona will acquire all of the outstanding shares of PAREXEL for $88.10 per share in cash in a transaction valued at approximately $5.0 billion, including PAREXEL’s net debt. Read Full Release
COTA
Hackensack Meridian Health taps IBM Watson for help on cancer treatments
06.05.17
IBM Watson Health, Cota Healthcare and Hackensack Meridian Health are partnering to test clinical decision support in cancer treatment, a pilot that will draw on Cota's precision-medicine database and Watson Health's artificial intelligence-enabled evidence-based recommendations. Read Full Release
Odyssey Logistics & Technology
Odyssey Logistics & Technology Recognized by Gartner in Magic Quadrant for North American 3PL
05.18.17
Danbury, Conn. (May 18, 2017) — Odyssey Logistics & Technology Corp. (Odyssey), a global leading logistics provider, today announced that it has been positioned by Gartner, Inc. on the “Magic Quadrant for Third Party Logistics Providers, North America” for 2017. This marks the first time Odyssey has been placed on the Gartner Magic Quadrant. Read Full Release
COTA
COTA, IBM Watson teaming up for pilot program at Hackensack Meridian
05.10.17
Imagine waiting for your diagnosis. The doctor walks in and says, “Well, I just consulted with everyone on the planet Earth over the last 30 years to see how they took care of people like you, and then I looked at a database that precisely looked at people who have exactly what you have, and are exactly like you, and this is what I have learned in the past five minutes, and this is why I am going to recommend this treatment.” Read Full Release
BC Platforms
BMP Founders Fund Company BC Platforms Closes $10M Series B
05.10.17
BC Platforms, a world leader in genomic data management solutions, today announces that it has closed a $USD 10 million financing round. The round was led by Debiopharm Innovation Fund in conjunction with Tesi, a Finnish venture capital and private equity company, and was supported by BC Platforms’ existing investors. BC Platforms will use the funds to launch new technologies in 2017 integrating complex clinical and genomic data in order to deliver precision medicine and clinical patient benefits, as well as to grow its existing genomic data management software business worldwide. Read Full Release
MedAptus
MedAptus Launches New Website
05.01.17
BMP Portfolio company MedAptus launches their new website. Click our link to take a tour. Read Full Release
COTA
New JTCC Studies Demonstrate Clinical and Economic Value of Genomic Profiling in Improving Care and Outcomes in Non-Small Cell Lung Cancer and Breast Cancer
06.14.16
Two new studies co-authored by researchers from John Theurer Cancer Center (JTCC) at Hackensack University Medical Center and discussed at the American Society of Clinical Oncology (ASCO) annual meeting demonstrate the potentially substantial therapeutic benefit of genomic profiling in serious, life-threatening cancers. Read Full Release
COTA
COTA Collaborates with Novartis Pharmaceuticals Corporation
03.27.17
Cota Healthcare, the leading data and technology platform for value-based precision medicine, today announced the signing of a major, multi-year collaboration with Novartis Pharmaceuticals Corporation to help improve clinical and cost outcomes for breast cancer patients. As part of this agreement, which expands significantly on the previous announced collaboration entered into January 2016, teams from across Novartis Pharmaceuticals Corporation will leverage Cota's research-grade, real-world evidence, web-based analysis and visualization tools, and be supported by Cota's medical, data science, and technology experts. Utilizing the real-world evidence and technology platform supplied by Cota is expected to enable Novartis Pharmaceuticals Corporation to accelerate clinical development of new therapies for breast cancer and identify which patients will benefit most. Read Full Release
Boston Millennia Partners
BMP Portfolio company Bivarus Raises $4 Million to Fuel Continued Growth
03.22.17
Bivarus, a patient-centered analytics company working with healthcare organizations to measure and analyze the patient experience and employee engagement, announced today it raised $4 million in a Series B from existing investors. Hatteras Venture Partnersled this latest financing round. Other participants in the round include Excelerate Health Ventures, Nashville-based NueCura Partners and Boston Millennia Partners. Read Full Release
Odyssey Logistics & Technology
Growth continues for Odyssey; move within Matrix planned
02.28.17
It was a year of growth in 2016 for Odyssey Logistics & Technology Corp. as it announced net revenue increased by 8 percent. In other words, 2016 was a typical year for the Danbury-based transportation company. Odyssey officials said the company has now experienced growth for 14 consecutive years. A major acquisition, maintaining a leadership position in key markets and expanding into new areas helped spur last year’s growth, Robert Shellman, president and CEO, said.... Read Full Release
COTA
Why Big Health Insurance is pouring money into startups
03.21.17
One effect of the Affordable Care Act, a.k.a. Obamacare? A spike in venture interest in health care startups. Digital health care companies raised $2.3 billion in the first half of 2014, which surpasses the total raised in all of 2013, according Rock Health, a health care-focused seed fund. That figure is impressive given that 2013 was already a record year at $1.9 billion raised. (That's a 39% increase year over year, even as biotech investment grew just 8% and medical devices investment fell by 17%.) Read Full Release
DCT
New AI Tool Improves Cognitive Testing
03.09.17
One good piece of news in recent years is that people around the world are living longer. The less good news is that older age exposes more of us to varieties of cognitive decline, including Alzheimer’s disease. According to the Alzheimer’s Association, the number of people with this diagnosis is likely to grow from around five million today to some 13.5 million in 2050. What could help stem this tsunami of pending illness? A team from MIT and Lahey Hospital and Medical Center has created a tool that will make it easier to detect cognitive impairment, enabling treatment to begin earlier and, potentially, improve outcomes. Read Full Release
COTA
Introducing Cota OCM™—A Solution for Practices Moving to Value-based Programs
02.10.17
Over the last year, our team at Cota has worked closely with providers and CMS—preparing for the eventual move to value-based payment under MACRA by studying the complexities of the law and building an OCM-specific technology solution on top of our CNA Guided Care™ platform. To address the obvious policy question up front: While the new administration has already planned or implemented sweeping changes across other areas, all indications (including these comments from former CMS head Andy Slavitt) point to Alternative Payment Models (APMs) and value-based payments sticking around for the long haul. In this post, we want to share what we’ve learned so far and officially announce Cota’s new technology solution specifically designed to help providers address the challenges and opportunities during this exciting time in the move value-based healthcare. Jump straight to the Cota OCM product announcement here. Read Full Release
Mingle Analytics
Looking Inside the Founder Forum: Dan Mingle of Mingle Analytics
01.11.17
Dan Mingle, as you’ll learn below, never thought of himself as an entrepreneur. He was just a doctor who while running his own physician practice in Norway, Maine, for more than a decade recognized a need for a more efficient healthcare system. Instead of being content with the lack of a solution, he saw an opportunity to execute on his ideas and play a part in improving the healthcare system and helping physicians like himself. Read Full Release
Boston Millennia Partners
Philips and Illumina join forces to offer integrated genomics solutions for oncology
01.10.17
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Illumina, Inc.(NASDAQ:ILMN), the global leader in DNA sequencing and array-based technologies, today announced a strategic collaboration, that aims to integrate Illumina’s sequencing systems for large-scale analysis of genetic variation and function and Philips’ IntelliSpace Genomics clinical informatics platform, and to coordinate marketing and sales of the resulting solutions. Philips and Illumina will also seek to engage in clinical research collaborations with health systems in the US who want to develop precision medicine programs in oncology. Read Full Release
PAREXEL International
PAREXEL Releases Consulting Regulatory Portal
01.10.17
Today's Challenge Problems will always arise, and establishing a right-first-time (RFT) environment is a one-time investment to deal with this inevitability. - See more at: https://www.parexel.com/regulatoryportal?utm_source=HBRprintedURL&utm_medium=print&utm_campaign=regulatoryhub#sthash.pG36KtGB.dpuf Read Full Release